Literature DB >> 6258385

Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.

A Ohlsson, M Widman, S Carlsson, T Ryman, C Strid.   

Abstract

The brain and plasma levels of unchanged delta 6-tetrahydrocannabinol (delta 6-THC), 7-hydroxy-delta 6-THC, the five side-chain hydroxylated delta 6-THC derivatives and 1 alpha, 2 alpha-epoxyhexahydrocannabinol (EHHC) were correlated to the cataleptic effect in the mouse up to 60 min. after intravenous administration of radiolabelled compounds in the range 1.3 to 12.4 mg/kg. All cannabinoids except delta 6-THC and 1"-hydroxy-delta 6-THC showed a very good correlation between brain/plasma concentrations and cataleptic effect. 4"-Hydroxy-and "1-hydroxy-delta 6-THC reached the highest concentration in the brain but the most potent cannabinoids were delta 6-THC, 7-hydroxy-, 3"-hydroxy-delta 6-THC, and EHHC followed by 5"-hydroxy-, 4"-hydroxy-, 2"-hydroxy-, and 1"-hydroxy-delta 6-THC in decreasing order. It was concluded that structural rather than pharmacokinetic features are most important in determining the psychoactivity of the various cannabinoid metabolites of THC.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6258385     DOI: 10.1111/j.1600-0773.1980.tb03660.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN: 0001-6683


  6 in total

1.  Comparative effects of pulmonary and parenteral Δ⁹-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats.

Authors:  Laurie A Manwell; Paul E Mallet
Journal:  Psychopharmacology (Berl)       Date:  2014-11-15       Impact factor: 4.530

2.  A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.

Authors:  S Burstein; S A Hunter; V Latham; L Renzulli
Journal:  Experientia       Date:  1987-04-15

Review 3.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

4.  The partitioning of delta 1-tetrahydrocannabinol into erythrocyte membranes in vivo and its effect on membrane fluidity.

Authors:  J T Leuschner; D R Wing; D J Harvey; G A Brent; C E Dempsey; A Watts; W D Paton
Journal:  Experientia       Date:  1984-08-15

Review 5.  Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome.

Authors:  Stephanie E Reuter; Jennifer H Martin
Journal:  Clin Pharmacokinet       Date:  2016-07       Impact factor: 6.447

6.  Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties.

Authors:  Lara Sharpe; Justin Sinclair; Andrew Kramer; Michael de Manincor; Jerome Sarris
Journal:  J Transl Med       Date:  2020-10-02       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.